UK Government Publishes Guidance for Life Sciences Companies on Brexit Transition

The UK Government has published guidance for life sciences companies on the Brexit implementation period, which is intended to take effect from 30 March 2019 to the end of 2020. If the draft Withdrawal Agreement is finalised by the UK and EU, during the implementation period the UK will no longer be an EU Member State but the UK and EU will continue to access each other’s market on broadly the same terms as at present.

The UK seeks to maintain 42 existing EU anti-dumping and anti-subsidy measures post-Brexit

But actions are needed from UK producers

On 28 November 2017, the UK Department for International Trade (DIT) announced that it would seek to maintain existing EU anti-dumping (AD) and anti-subsidy (AS) measures post-Brexit 

Brexit, medical devices and transfer of notified bodies: what will be the procedure?

n the recently published White Paper governing the future relationship between the United Kingdom and the European Union, the UK proposes a "common rulebook" between the parties in relation to goods. The White Paper discusses what is foreseen as the future relationship between the parties in some detail. This includes the expectation that goods' manufacturers should be required to undergo only one series of tests in either the EU or the UK, in order to place products in both markets. According to the White Paper, this approach would be "underpinned by strong reciprocal commitments to open and fair trade and a robust institutional framework".

UK Government presents its draft schedule of commitments for goods in Geneva

International trade law is about to become a whole lot more relevant to UK businesses, as the UK is going ahead in fledgling its independent trade policy. 

Mind the gaffe: Parliament's scrutiny committee gives business five days to spot the Government's Brexit blunders

London is in the midst of a heatwave but a storm has hit Westminster.  The Government has begun publishing the draft statutory instruments (SIs) it intends to adopt using its new delegated power in the European Union (Withdrawal) Act 2018 (EUWA 2018) to correct deficiencies in retained EU law post-Brexit. 

Tick tock on the Brexit clock; a view from the Continent

As we painfully inch forward toward what may be the Brexit finish line, national regulators are firing shots across the bow of UK financial institutions carrying out activities in Continental Europe. Earlier this week, the Financial Times reported that " Banque de France officials sent out emails to UK fintech companies requesting their Brexit strategy details of contingency.  

Trade Bill amendment on medicines post-Brexit passed

MPs have voted to accept an amendment to the Trade Bill that requires the UK Government to make continued UK participation in the EU/EEA medicines regulatory network, including the European Medicines Agency (EMA), a negotiating objective in trade discussions with the EU

Brexit White Paper: setting the first stones of the UK trade position

On 12 July, the UK government published its long-awaited White Paper on "The future relationship between the United Kingdom and the European Union". One major focus was the UK's future trade arrangements, both with the EU and worldwide. Below, we set out some thoughts on these proposals, their effect on the UK trade and likely responses from the EU.

Brexit White Paper: a digital Brexit?

The UK Government's White Paper sets out detailed proposals for the UK's relationship with the EU following Brexit.

As described in our dissection of the document as a whole, the White Paper sees the digital economy as an area of global opportunity for the UK.   So what does the Government have to say about sector?

Brexit White Paper: positive for life sciences

The White Paper appears largely positive for the life sciences industry, incorporating many of the key asks from the industry across its priority areas of regulation, trade, people and innovation. On regulation, the proposed "common rulebook" for goods would mean continued regulatory alignment between the EU and UK for medicines and medical devices. 

Brexit White Paper: data without borders

The UK Government is realistically ambitious in terms of achieving two objectives: (a) the continued exchange of personal data between the UK and the EU, and (b) the ICO’s participation in the One Stop Shop mechanism of regulatory oversight.

Brexit White Paper: questions remain for the Real Estate sector

The White Paper leaves many of the real estate sector's questions unanswered. Whilst it will be some comfort to developers that there will be free movement of goods, hopefully limiting the impact of Brexit on the availability and cost of materials, lack of clarity on immigration rules remains a concern. The building industry employs many EU citizens, and a Government review has already acknowledged that a shortage of bricklayers is a potential barrier to achieving the Government's targets on housebuilding. This situation is only likely to be exacerbated by ending the free movement of people.